In this Section |
262084 Peripartum cardiomyopathy and obesity among maternal deaths in CaliforniaWednesday, October 31, 2012
Background/Methods: The California Pregnancy-Associated Mortality Review (CA-PAMR) is a public health project funded from Title V MCAH Block Grants to review pregnancy-related deaths in order to identify causes of death, contributing factors, and opportunities for improvement. Based on review of 145 cases from 2002-2004, peripartum cardiomyopathy is now the second leading cause of pregnancy-related death in California. CA-PAMR data was used to examine the characteristics of women who died from cardiomyopathy.
Results: Peripartum cardiomyopathy accounted for 19 (13%) of the 145 deaths. Among these, 58% were obese (BMI≥30) and 89% were overweight or obese (BMI≥25). Women who died of cardiomyopathy were significantly more likely to be obese than those who died from other causes combined (58% vs. 21% respectively, p<.05) and to have had excessive gestational weight gain. African-American women were almost four times as likely as all other racial/ethnic groups combined to die from cardiomyopathy (27% vs. 9% respectively, p<.05) and were more likely than other groups to be obese (p<.01). Cardiomyopathy deaths occurred later than other maternal deaths, with a mean of 103 days postpartum versus 13 days respectively (p<.01). The leading contributing factors identified were: pre-existing medical conditions (63%); delay in diagnosis or treatment (47%); lack of continuity of care (47%) and obesity (47%). There was a good/strong chance to have altered the outcome in 26% of the cardiomyopathy deaths. Conclusion: Peripartum cardiomyopathy is now a leading cause of pregnancy-related death. Overweight and obese women and African-American women are at higher risk of maternal death from cardiomyopathy.
Learning Areas:
Chronic disease management and preventionEpidemiology Learning Objectives: Keywords: Obesity, Heart Disease
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have worked in maternal and reproductive health research for over 10 years. I manage the data collection and analysis for the Pregnancy-Associated Mortality Review. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 5023.0: Perinatal and Women's Health Poster Session
|